cystic fibrosis

pause button on blue background
Biotech

Vertex takes $379M hit tied to cancelled islet cell program

Vertex announced a $379 million impairment charge tied to its earlier discontinuation of a clinical-stage islet cell treatment for diabetes.
Gabrielle Masson May 6, 2025 12:50pm
Photo of Wall Street street sign with american flags in the background

Sionna goes public in $135M IPO, Aardvark plots $103M listing

Feb 7, 2025 4:40am
IPO initial public offering

Sionna eyes up $156M IPO to fund cystic fibrosis trials

Feb 3, 2025 9:59am
IPO initial public offering Wall Street

Odyssey, Sionna join band of biotechs braving the IPO waters

Jan 21, 2025 5:27am
x ray cystic fibrosis

Sionna salvages AbbVie assets for assault on cystic fibrosis

Jul 16, 2024 10:00am
pipeline pipes RD research

enGene drops cystic fibrosis program to focus on bladder cancer

Jun 14, 2024 8:20am